Obstet Gynecol Sci.  2013 Jul;56(4):217-226.

Technique of fetal echocardiography

• Lee MY
• Won HS

Abstract

Congenital heart disease is the most common abnormality in the human fetus. Fetal echocardiography has been used to detect the majority of cardiac defects, and it is now part of the routine screening method for fetal evaluation. In this article, we present standard ultrasonographic views of the normal fetal heart obtained during the second trimester, first-trimester fetal echocardiography findings, and a modified myocardial performance index.

Keyword

Congenital; Echocardiography; Fetal heart; Heart defects; Prenatal diagnosis

MeSH Terms

Echocardiography
Female
Fetal Heart
Fetus
Heart Diseases
Humans
Mass Screening
Pregnancy
Pregnancy Trimester, Second
Prenatal Diagnosis

Reference

1. Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978. 42:641–647.

2. Bronshtein M, Gover A, Zimmer EZ. Sonographic definition of the fetal situs. Obstet Gynecol. 2002. 99:1129–1130.

3. Allan LD. A practical approach to fetal heart scanning. Semin Perinatol. 2000. 24:324–330.

4. Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. 1990. 65:20–23.

5. Chaoui R, Bollmann R, Goldner B, Heling KS, Tennstedt C. Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther. 1994. 9:92–104.

6. Comstock CH. Normal fetal heart axis and position. Obstet Gynecol. 1987. 70:255–259.

7. Allan L. Technique of fetal echocardiography. Pediatr Cardiol. 2004. 25:223–233.

8. Jung E, Won HS, Lee PR, Kim A, Park IS. Clinical implication of isolated right dominant heart in the fetus. Prenat Diagn. 2007. 27:695–698.

9. Rizzo G, Arduini D, Romanini C. Doppler echocardiographic assessment of fetal cardiac function. Ultrasound Obstet Gynecol. 1992. 2:434–445.

10. Allan LD, Chita SK, Al-Ghazali W, Crawford DC, Tynan M. Doppler echocardiographic evaluation of the normal human fetal heart. Br Heart J. 1987. 57:528–533.

11. Reed KL, Anderson CF, Shenker L. Fetal pulmonary artery and aorta: two-dimensional Doppler echocardiography. Obstet Gynecol. 1987. 69:175–178.

12. Yoo SJ, Lee YH, Kim ES, Ryu HM, Kim MY, Choi HK, et al. Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol. 1997. 9:173–182.

13. Pasquini L, Mellander M, Seale A, Matsui H, Roughton M, Ho SY, et al. Z-scores of the fetal aortic isthmus and duct: an aid to assessing arch hypoplasia. Ultrasound Obstet Gynecol. 2007. 29:628–633.

14. Abuhamad A, Chaoui R. Abuhamad A, Chaoui R, editors. The great vessels. A practical guide to fetal echocardiography. 2010. 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins;60–76.

15. Gembruch U, Knopfle G, Chatterjee M, Bald R, Hansmann M. First-trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol. 1990. 75:496–498.

16. Bronshtein M, Zimmer EZ, Milo S, Ho SY, Lorber A, Gerlis LM. Fetal cardiac abnormalities detected by transvaginal sonography at 12-16 weeks’ gestation. Obstet Gynecol. 1991. 78:374–378.

17. Gembruch U, Knopfle G, Bald R, Hansmann M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol. 1993. 3:310–317.

18. Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan B, Shinebourne EA. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart. 2004. 90:921–926.

19. Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol. 1997. 10:242–246.

20. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol. 1999. 14:307–310.

21. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol. 1995. 26:357–366.

22. Hernandez-Andrade E, Lopez-Tenorio J, Figueroa-Diesel H, Sanin-Blair J, Carreras E, Cabero L, et al. A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function assessment. Ultrasound Obstet Gynecol. 2005. 26:227–232.

23. Api O, Emeksiz MB, Api M, Ugurel V, Unal O. Modified myocardial performance index for evaluation of fetal cardiac function in pre-eclampsia. Ultrasound Obstet Gynecol. 2009. 33:51–57.

24. Hernandez-Andrade E, Crispi F, Benavides-Serralde JA, Plasencia W, Diesel HF, Eixarch E, et al. Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth-restricted fetuses. Ultrasound Obstet Gynecol. 2009. 34:430–436.

25. Figueroa H, Silva MC, Kottmann C, Viguera S, Valenzuela I, Hernandez-Andrade E, et al. Fetal evaluation of the modified-myocardial performance index in pregnancies complicated by diabetes. Prenat Diagn. 2012. 32:943–948.

26. Van Mieghem T, Klaritsch P, Done E, Gucciardo L, Lewi P, Verhaeghe J, et al. Assessment of fetal cardiac function before and after therapy for twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 2009. 200:400.e1–400.e7.